MedPath

Clinical evaluation of different topical formulations of Fumaria officinalis extract on the Vitiligo and analysis of its Fumaric acid content by HPLC.

Phase 2
Conditions
vitiligo.
disorders of pigmentation
Registration Number
IRCT201111108022N1
Lead Sponsor
Vice chancellor for research, Kermanshah University Of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

lasting more than 6 month after diagnosis, age 11-60, filling informed consent. Exclusion criterion: Pregnancy, Lactation, not filling consent form.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Repigmentation rate after treatment. Timepoint: Every 2weeks during 4 months. Method of measurement: Observtion.
Secondary Outcome Measures
NameTimeMethod
Diameter reduction. Timepoint: every 2 weeks during 4 months. Method of measurement: Evaluation of diameter with precise measurement.
© Copyright 2025. All Rights Reserved by MedPath